subject: Molecular Diagnostics Is The Fastest Growing Segment In The In Vitro Diagnostics Market [print this page] Global In Vitro Diagnostics (IVD) Market Trends and Future Forecast (2009 - 2014)
The report provides market landscape, competitive landscape and market trends information on ten market categories including Molecular Diagnostics, Clinical Chemistry, Hematology, Immunoassay, Point of Care Testing, Microbiology, Histology/Cytology, Flow Cytometry, Blood Screening Typing, and Coagulation. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings. The report also analyses past present and future forecast of USA, Japan, Europe, India, China and Taiwan IVD market. ( http://www.bharatbook.com/detail.asp?id=150732&rt=Global-In-Vitro-Diagnostics-IVDMarket-Trends-and-Future-Forecast-2009-2014.html )
The report has been researched at source globally and features latest available data covering:
Ten IVD sub-segment past, present and future forecast market share
Six countries (USA, Japan, Europe, India, China, Taiwan) past, present, future prospects in the IVD market
Top eight companies (Sysmex, BioMerieux, OCD (J&J), Beckman Coulter, BD, Abbott Diagnostics, Siemens & Roche) IVD market share in 2009
Top ten Merger & Acquisition deals in 2008 and 2009
Licensing by ten IVD players
Review of International In Vitro Diagnostics Regulations
Key drivers of growth in the global IVD market
Key challenges faces by IVD market in the coming years
Research Highlights
Globally, In Vitro Diagnostics market will cross US$ 60 Billion by 2014
Point of Care Testing dominates the In Vitro Diagnostics market with more than 30% market share in 2009
Molecular Diagnostics is the fastest growing segment in the In Vitro Diagnostics market, its market share will reach approximately 18% by 2014
In 2009 Roche, Siemens and Abbott Diagnostics together controls 42% market share in In Vitro Diagnostics, Roche controls the highest market share
After Point of Care Testing, Immunoassay is the second largest market with a market of more than US$ 7 Billion in 2009
Europe with more than US$ 10 Billion is the second largest In Vitro Diagnostics Market in 2009
51 Mergers & Acquisitions taken place in 2008 compared to 84 deals in 2007
18 In-Licensing deals were announced in 2008 compared to 27 in 2007
By 2009 there were 12 countries with more than 10 Million people aged 60 or over
Third Wave Technologies (TWT) was acquired by Hologic to grow its existing womens health and diagnostics business was the best deal in 2008
In 2009, Beckman Coulter acquired the diagnostic systems part of Olympuss life sciences to broaden its clinical chemistry offering, especially in the ultra-high throughput setting.
For more information kindly visit : http://www.bharatbook.com/detail.asp?id=150732&rt=Global-In-Vitro-Diagnostics-IVDMarket-Trends-and-Future-Forecast-2009-2014.html
Related Reports
The Future of the In-Vitro Diagnostics Market to 2016 - Increasing Diagnostic Procedures Drive Demand
